I'm just saying toxic funding. NGIO appears to be the only way out if even such a big deal goes by the wayside. Ok, the FDA has to approve or accept the vaccination process, but this deal calls for higher rates.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links